Animal spirits: Zenex investors dial bankers for $1 billion sale or IPO

After Advent's Felix Pharma buyout, another deal is brewing in the vet medicine segment. Multiples and other investors of Zenex Animal Health are looking at a full sale or an IPO, potentially valuing the company at $1 billion

Companies